These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9625265)

  • 1. Omission of the deconjugation step in urine analysis and the unaltered outcome of CYP2D6 phenotyping with dextromethorphan.
    Basci NE; Bozkurt A; Kayaalp SO; Sayal A; Isimer A
    Eur J Drug Metab Pharmacokinet; 1998; 23(1):1-5. PubMed ID: 9625265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice.
    Jurica J; Bartecek R; Zourkova A; Pindurova E; Sulcova A; Kasparek T; Zendulka O
    J Clin Pharm Ther; 2012 Aug; 37(4):486-90. PubMed ID: 22548589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substrates.
    Labbé L; Sirois C; Pilote S; Arseneault M; Robitaille NM; Turgeon J; Hamelin BA
    Pharmacogenetics; 2000 Jul; 10(5):425-38. PubMed ID: 10898112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel single-point plasma or saliva dextromethorphan method for determining CYP2D6 activity.
    Hu OY; Tang HS; Lane HY; Chang WH; Hu TM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):955-60. PubMed ID: 9618394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.
    Capon DA; Bochner F; Kerry N; Mikus G; Danz C; Somogyi AA
    Clin Pharmacol Ther; 1996 Sep; 60(3):295-307. PubMed ID: 8841152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of terbinafine as a CYP2D6 inhibitor in vivo.
    Abdel-Rahman SM; Gotschall RR; Kauffman RE; Leeder JS; Kearns GL
    Clin Pharmacol Ther; 1999 May; 65(5):465-72. PubMed ID: 10340911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping.
    Streetman DS; Ellis RE; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 1999 Nov; 66(5):535-41. PubMed ID: 10579482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance.
    Borges S; Li L; Hamman MA; Jones DR; Hall SD; Gorski JC
    Drug Metab Dispos; 2005 Jul; 33(7):1052-5. PubMed ID: 15821042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and polymorphic oxidation of dextromethorphan in a Japanese population.
    Nagai N; Kawakubo T; Kaneko F; Ishii M; Shinohara R; Saito Y; Shimamura H; Ohnishi A; Ogata H
    Biopharm Drug Dispos; 1996 Jul; 17(5):421-33. PubMed ID: 8830977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan.
    Kévorkian JP; Michel C; Hofmann U; Jacqz-Aigrain E; Kroemer HK; Peraldi MN; Eichelbaum M; Jaillon P; Funck-Brentano C
    Clin Pharmacol Ther; 1996 May; 59(5):583-92. PubMed ID: 8646830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism of CYP2D6 and CYP2C19 metabolism determined by phenotyping Israeli ethnic groups.
    Britzi M; Bialer M; Arcavi L; Shachbari A; Kapitulnik T; Soback S
    Ther Drug Monit; 2000 Oct; 22(5):510-6. PubMed ID: 11034254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vivo indices of CYP2D6 activity: comparison of dextromethorphan metabolic ratios in 4-h urine and 3-h plasma.
    Chládek J; Zimová G; Beránek M; Martínková J
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):651-7. PubMed ID: 11214771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2D6 phenotyping with dextromethorphan.
    Wojtczak A; Rychlik-Sych M; Krochmalska-Ulacha E; Skretkowicz J
    Pharmacol Rep; 2007; 59(6):734-8. PubMed ID: 18195464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified high-performance liquid chromatographic method to measure both dextromethorphan and proguanil for oxidative phenotyping.
    Hoskins JM; Shenfield GM; Gross AS
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(1):81-7. PubMed ID: 9300912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism of CYP2D6 in North Indian subjects.
    Lamba V; Lamba JK; Dilawari JB; Kohli KK
    Eur J Clin Pharmacol; 1998; 54(9-10):787-91. PubMed ID: 9923585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition.
    Schadel M; Wu D; Otton SV; Kalow W; Sellers EM
    J Clin Psychopharmacol; 1995 Aug; 15(4):263-9. PubMed ID: 7593709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation.
    Jones DR; Gorski JC; Haehner BD; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1996 Oct; 60(4):374-84. PubMed ID: 8873685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of CYP2D6 and CYP2C19 activity in vivo in humans: a cocktail study with dextromethorphan and chloroguanide alone and in combination.
    Tennezé L; Verstuyft C; Becquemont L; Poirier JM; Wilkinson GR; Funck-Brentano C
    Clin Pharmacol Ther; 1999 Dec; 66(6):582-8. PubMed ID: 10613613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2D6 genotype and phenotyping by determination of dextromethorphan and metabolites in serum of healthy controls and of patients under psychotropic medication.
    Köhler D; Härtter S; Fuchs K; Sieghart W; Hiemke C
    Pharmacogenetics; 1997 Dec; 7(6):453-61. PubMed ID: 9429230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cytochrome P450 2D6 phenotyping in healthy adult Western Indians.
    Gogtay NJ; Mali NB; Iyer K; Kadam PP; Sridharan K; Shrimal D; Thatte UM
    Indian J Pharmacol; 2014; 46(3):266-9. PubMed ID: 24987171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.